VG
Garibotto, Valentina
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Deep learning-guided attenuation and scatter correction of 99mTc-MAA SPECT images: towards quantitative analysis in 90Y-SIRT | Annals of nuclear medicine | 2026 | 17 | 154 | |||
| Multimodal Fusion and Transfer Learning for the Detection of Degenerative Parkinsonisms with Dopamine Transporter SPECT Imaging | Journal of imaging informatics in medicine | 2026 | 1 | 0 | |||
| Performance Evaluation of the Time-of-Flight Biograph Vision.X : A Fast Coincidence Time Resolution PET/CT Scanner | IEEE transactions on radiation and plasma medical sciences | 2025 | 2 | 23 | |||
| Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease | Neurology | 2025 | 13 | 115 | |||
| TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s disease | Journal of neuroinflammation | 2025 | 30 | 20 | |||
| Dopaminergic deficits along the spectrum of Alzheimer’s disease | Molecular psychiatry | 2025 | 14 | 0 | |||
| Early-phase 18F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer’s disease: a comparison with 18F-FDG-PET and early-phase amyloid-PET | European journal of nuclear medicine and molecular imaging | 2025 | 15 | 81 | |||
| Resilience in Alzheimer's disease: Impact of operationalization and methodological choices | Alzheimer's & dementia | 2025 | 123 | 194 | |||
| Is early-phase amyloid PET ready for use as neurodegeneration marker ? | Journal of Alzheimer's disease | 2025 | 7 | 49 | |||
| Proximal tibiofibular synostosis in HDP SPECT/CT bone scan: A case report | Radiology case reports | 2025 | 3 | 7 | |||
| Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) 18F-FDG-PET pattern in amnestic mild cognitive impairment | European journal of nuclear medicine and molecular imaging | 2025 | 17 | 258 | |||
| Radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans | Nuclear medicine and biology | 2025 | 66 | 0 | |||
| Potential of Radiomics, Dosiomics, and Dose Volume Histograms for Tumor Response Prediction in Hepatocellular Carcinoma following 90Y-SIRT | Molecular imaging and biology | 2025 | 42 | 48 | |||
| Deep learning-based triple-tracer brain PET scanning in a single session : A simulation study using clinical data | NeuroImage | 2025 | 40 | 38 | |||
| Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline | Brain | 2024 | 9 | 88 | |||
| Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia : an updated systematic review | European journal of nuclear medicine and molecular imaging | 2024 | 95 | 0 | |||
| Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort | Journal of neurology | 2024 | 116 | 45 | |||
| A comparison of visual assessment and semi-quantification for the diagnostic and prognostic use of [18F]flortaucipir PET in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | 2024 | 88 | 68 | |||
| Yield of non-invasive imaging in MRI-negative focal epilepsy | Journal of neurology | 2024 | 85 | 155 | |||
| Neurological disorders and women's health : contribution of molecular neuroimaging techniques | Seminars in nuclear medicine | 2024 | 85 | 0 | |||
| Molecular imaging of acute graft-versus-host disease | The Journal of nuclear medicine | 2024 | 87 | 150 | |||
| A deep learning model for generating [18F]FDG PET Images from early-phase [18F]Florbetapir and [18F]Flutemetamol PET images | European journal of nuclear medicine and molecular imaging | 2024 | 128 | 82 | |||
| Fingerprints of brain disease : connectome identifiability in Alzheimer's disease | Communications biology | 2024 | 202 | 80 | |||
| European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders | Lancet neurology | 2024 | 122 | 0 | |||
| Mapping brain metabolism, connectivity and neurotransmitters topography in early and late onset dementia with lewy bodies | Parkinsonism & related disorders | 2024 | 74 | 0 | |||
| EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy | European journal of nuclear medicine and molecular imaging | 2024 | 68 | 1,208 | |||
| Tracer-Separator : A Deep Learning Model for Brain PET Dual-Tracer (18F-FDG and Amyloid) Separation | Clinical nuclear medicine | 2024 | 59 | 381 | |||
| Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients | Alzheimer's research & therapy | 2024 | 154 | 143 | |||
| The role of biomarkers and dosimetry parameters in overall and progression free survival prediction for patients treated with personalized 90Y glass microspheres SIRT : a preliminary machine learning study | European journal of nuclear medicine and molecular imaging | 2024 | 122 | 64 | |||
| Alterations in gamma frequency oscillations correlate with cortical tau deposition in Alzheimer’s disease | Neurobiology of aging | 2024 | 124 | 161 | |||
| Electroencephalographic Abnormalities in a Patient Suffering from Long-Term Neuropsychological Complications following SARS-CoV-2 Infection | Case reports in neurology | 2024 | 88 | 91 | |||
| Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats | Journal of Alzheimer's disease | 2024 | 91 | 52 | |||
| Distinctive clinical and imaging trajectories in SWEDD and Parkinson's disease patients | NeuroImage. Clinical | 2024 | 67 | 44 | |||
| PET Imaging in Dementia : Mini-Review and Canadian Perspective for Clinical Use | Canadian journal of neurological sciences | 2024 | 72 | 363 | |||
| Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease | Neurology | 2024 | 103 | 109 | |||
| The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline | Alzheimer's & dementia | 2024 | 129 | 139 | |||
| In Vivo Tau and Neurodegeneration Imaging in a Family With the Presenilin 1 Met146Leu Pathogenic Variant | Neurology | 2024 | 8 | 36 | |||
| Impact of simulated reduced injected dose on the assessment of amyloid PET scans | European journal of nuclear medicine and molecular imaging | 2024 | 140 | 41 | |||
| Automatic Classification of Conclusions from Multi-Tracer Reports of PET Brain Imaging in Cognitive Impairment | Studies in health technology and informatics | 2024 | 149 | 100 | |||
| [68Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria | The Journal of nuclear medicine | 2024 | 40 | 0 | |||
| 18 kDa Translocator Protein TSPO Is a Mediator of Astrocyte Reactivity | ACS omega | 2023 | 207 | 71 | |||
| Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer's disease | European journal of nuclear medicine and molecular imaging | 2023 | 83 | 233 | |||
| Nonlesional epilepsy—a case report in adult epileptology | Clinical epileptology | 2023 | 128 | 31 | |||
| International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer's Disease | Phenomics | 2023 | 59 | 105 | |||
| The Clinical Added Value of Breast Cancer Imaging Using Hybrid PET/MR Imaging | Magnetic resonance imaging clinics of North America | 2023 | 82 | 3 | |||
| PET/MR Imaging in Clinical Practice: After Expectations and (Some) Disillusion, a Slope of Enlightenment | Magnetic resonance imaging clinics of North America | 2023 | 172 | 130 | |||
| Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic | Journal of neurology, neurosurgery and psychiatry | 2023 | 266 | 172 | |||
| Sex differences in brain metabolic connectivity architecture in probable dementia with Lewy bodies | Neurobiology of aging | 2023 | 101 | 0 | |||
| The Early Diagnosis of Alzheimer's Disease: A Patient-Centred Conversation with the Care Team | Neurology and therapy | 2023 | 105 | 328 | |||
| Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool | Journal of neurochemistry | 2023 | 130 | 184 | |||
| Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study | Alzheimer's & dementia | 2023 | 147 | 153 | |||
| Unusual phosphaturic mesenchymal tumor mimicking osteoid osteoma | Radiology case reports | 2023 | 154 | 132 | |||
| Prognostic value of imaging-based ATN profiles in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | 2023 | 99 | 94 | |||
| Analysis of psychological symptoms following disclosure of amyloid-positron emission tomography imaging results to adults with subjective cognitive decline | JAMA network open | 2023 | 94 | 105 | |||
| Patterns of amyloid accumulation in amyloid-negative cases | Neurobiology of aging | 2023 | 75 | 31 | |||
| A cycle-consistent adversarial network for brain PET partial volume correction without prior anatomical information | European journal of nuclear medicine and molecular imaging | 2023 | 245 | 51 | |||
| ATN profile classification across two independent prospective cohorts | Frontiers in medicine | 2023 | 137 | 116 | |||
| Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients : The AMYPAD-DPMS Randomized Clinical Trial | JAMA neurology | 2023 | 72 | 65 | |||
| European consensus for the diagnosis of MCI and mild dementia: Preparatory phase | Alzheimer's & dementia | 2023 | 132 | 84 | |||
| Sex differences in dementia with Lewy bodies: an imaging study of neurotransmission pathways | European journal of nuclear medicine and molecular imaging | 2023 | 117 | 74 | |||
| Predictive value of 99mTc-MAA-based dosimetry in personalized 90Y-SIRT planning for liver malignancies | EJNMMI research | 2023 | 98 | 37 | |||
| Dementia prevention in memory clinics : recommendations from the european task force for brain health services | The Lancet regional health. Europe | 2023 | 118 | 187 | |||
| Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission | European journal of nuclear medicine and molecular imaging | 2023 | 109 | 31 | |||
| Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease | Frontiers in neurology | 2023 | 53 | 31 | |||
| Reactive astrocytes mediate TSPO overexpression in response to sustained CNTF exposure in the rat striatum | Molecular brain | 2023 | 196 | 56 | |||
| Contrast enhanced CT on PET/CT imaging in clinical routine: an international survey | Frontiers in medicine | 2023 | 94 | 81 | |||
| Early-phase 18F-Florbetapir and 18F-Flutemetamol images as proxies of brain metabolism in a memory clinic setting | The Journal of nuclear medicine | 2023 | 179 | 228 | |||
| 2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS | European journal of nuclear medicine and molecular imaging | 2022 | 38 | 0 | |||
| EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3 | European journal of nuclear medicine and molecular imaging | 2022 | 77 | 234 | |||
| Low-dose brain irradiation normalizes TSPO and CLUSTERIN levels and promotes the non-amyloidogenic pathway in pre-symptomatic TgF344-AD rats | Journal of neuroinflammation | 2022 | 192 | 70 | |||
| Lifelong bilingualism and mechanisms of neuroprotection in Alzheimer dementia | Human brain mapping | 2022 | 64 | 29 | |||
| Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson's disease | Frontiers in medicine | 2022 | 119 | 123 | |||
| Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice | Journal of Alzheimer's disease | 2022 | 358 | 1 | |||
| Detection of distant metastases and distant second primary cancers in head and neck squamous cell carcinoma: comparison of [18F]FDG PET/MRI and [18F]FDG PET/CT | Insights into imaging | 2022 | 239 | 207 | |||
| High density electric source imaging in childhood-onset epilepsy due to focal cortical dysplasia | Clinical neurophysiology practice | 2022 | 58 | 150 | |||
| Adopting transfer learning for neuroimaging: a comparative analysis with a custom 3D convolution neural network model | BMC medical informatics and decision making | 2022 | 110 | 28 | |||
| Quantification of amyloid PET for future clinical use: a state-of-the-art review | European journal of nuclear medicine and molecular imaging | 2022 | 54 | 547 | |||
| Impact of cerebral blood flow and amyloid load on SUVR bias | EJNMMI research | 2022 | 128 | 179 | |||
| Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis | Diagnostics | 2022 | 96 | 69 | |||
| A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET | European journal of nuclear medicine and molecular imaging | 2022 | 421 | 92 | |||
| [18F]FDOPA positron emission tomography for cardiac innervation imaging : a new way or a dead-end street? | Clinical autonomic research | 2022 | 157 | 65 | |||
| Simulad: a dynamical model for personalized simulation and disease staging in alzheimer's disease | Neurobiology of aging | 2022 | 136 | 52 | |||
| The Biological Substrate of the Motoric Cognitive Risk Syndrome: A Pilot Study Using Amyloid-/Tau-PET and MR Imaging | Journal of Alzheimer's disease | 2022 | 213 | 119 | |||
| International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer's disease | European journal of nuclear medicine and molecular imaging | 2022 | 67 | 0 | |||
| The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-19 | Neurodegenerative diseases | 2022 | 125 | 202 | |||
| Gender issues in the nuclear medicine community : results from a survey promoted by the EANM Women Empowerment Task Force | European journal of nuclear medicine and molecular imaging | 2022 | 61 | 35 | |||
| The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey | Journal of Alzheimer's disease | 2022 | 95 | 173 | |||
| Personality Impact on Alzheimer's Disease - Signature and Vascular Imaging Markers: A PET-MRI Study | Journal of Alzheimer's disease | 2022 | 113 | 0 | |||
| Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging | 2021 | 285 | 277 | |||
| Finding our way through the labyrinth of dementia biomarkers | European journal of nuclear medicine and molecular imaging | 2021 | 170 | 0 | |||
| Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison | European Journal of Nuclear Medicine and Molecular Imaging | 2021 | 343 | 210 | |||
| Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design | Alzheimer's Research and Therapy | 2021 | 446 | 371 | |||
| Determinants of Cognitive Trajectories in Normal Aging: A Longitudinal PET-MRI Study in a Community-based Cohort | Current Alzheimer research | 2021 | 317 | 3 | |||
| The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers | European journal of nuclear medicine and molecular imaging | 2021 | 222 | 239 | |||
| Premotor and fronto-striatal mechanisms associated with presence hallucinations in dementia with Lewy bodies | NeuroImage: Clinical | 2021 | 244 | 210 | |||
| Prediction of Subtle Cognitive Decline in Normal Aging: Added Value of Quantitative MRI and PET Imaging | Frontiers in aging neuroscience | 2021 | 205 | 122 | |||
| PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls | Seminars in nuclear medicine | 2021 | 169 | 0 | |||
| Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European‐DLB consortium project | Alzheimer's & Dementia | 2021 | 273 | 2 | |||
| Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services — part 2 of 6 | Alzheimer's research & therapy | 2021 | 162 | 242 | |||
| 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging | 2021 | 244 | 284 | |||
| Biomarkers to Evaluate Androgen Deprivation Therapy for Prostate Cancer and Risk of Alzheimer's Disease and Neurodegeneration: Old Drugs, New Concerns | Frontiers in oncology | 2021 | 115 | 89 | |||
| Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome | Journal of Alzheimer's disease | 2021 | 216 | 0 | |||
| Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives | European journal of nuclear medicine and molecular imaging | 2021 | 226 | 117 | |||
| Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services — part 6 of 6 | Alzheimer's research & therapy | 2021 | 128 | 120 | |||
| Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework | European journal of nuclear medicine and molecular imaging | 2021 | 266 | 245 | |||
| PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy: Impact on Treatment Management and Future Directions | Frontiers in oncology | 2021 | 211 | 210 | |||
| Treatment by low-dose brain radiation therapy improves memory performances without changes of the amyloid load in the TgF344-AD rat model | Neurobiology of Aging | 2021 | 398 | 267 | |||
| Molecular Imaging Approaches in Dementia | Radiology | 2021 | 279 | 259 | |||
| The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update | European Journal of Nuclear Medicine and Molecular Imaging | 2021 | 356 | 253 | |||
| In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer's disease phases | Alzheimer's research & therapy | 2021 | 101 | 36 | |||
| Appropriate use criteria for dementia amyloid imaging in Switzerland – mini-review and statement on behalf of the Swiss Society of Nuclear Medicine and the Swiss Memory Clinics | Nuclear-Medizin | 2021 | 269 | 0 | |||
| The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community | European journal of nuclear medicine and molecular imaging | 2021 | 186 | 0 | |||
| PET imaging of dopamine neurotransmission during EEG neurofeedback | Frontiers in Physiology | 2021 | 416 | 178 | |||
| Clinical Characterization of Atypical Primary Progressive Aphasia in a 3-Year Longitudinal Study: A Case Report | Cognitive and behavioral neurology | 2021 | 184 | 1 | |||
| Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging | 2021 | 197 | 90 | |||
| Molecular imaging and fluid biomarkers of Alzheimer's disease neuropathology: an opportunity for integrated diagnostics | European journal of nuclear medicine and molecular imaging | 2021 | 241 | 0 | |||
| A kinetics-based approach to amyloid PET semi-quantification | European Journal of Nuclear Medicine and Molecular Imaging | 2020 | 184 | 0 | |||
| Nicotinic Acetylcholine Receptor Density in the "Higher-Order" Thalamus Projecting to the Prefrontal Cortex in Humans: a PET Study | Molecular Imaging and Biology | 2020 | 323 | 0 | |||
| Personality Factors' Impact on the Structural Integrity of Mentalizing Network in Old Age: A Combined PET-MRI Study | Frontiers in Psychiatry | 2020 | 199 | 141 | |||
| Localizing non-epileptiform abnormal brain function in children using high density EEG: Electric Source Imaging of focal slowing | Epilepsy Research | 2020 | 379 | 0 | |||
| Determinants of mesial temporal lobe volume loss in older individuals with preserved cognition: a longitudinal PET amyloid study | Neurobiology of Aging | 2020 | 279 | 0 | |||
| Low-Dose Radiation Therapy: A New Treatment Strategy for Alzheimer's Disease? | Journal of Alzheimer's Disease | 2020 | 527 | 2 | |||
| In Vivo TSPO Signal and Neuroinflammation in Alzheimer's Disease | Cells | 2020 | 276 | 164 | |||
| Highlights of the 32th Annual Congress of the EANM, Barcelona 2019: the nucleolympic games of nuclear medicine-a global competition for excellence | European Journal of Nuclear Medicine and Molecular Imaging | 2020 | 195 | 0 | |||
| Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias | Lancet neurology | 2020 | 277 | 0 | |||
| Multitracer model for staging cortical amyloid deposition using PET imaging | Neurology | 2020 | 14 | 58 | |||
| PET amyloid in normal aging: direct comparison of visual and automatic processing methods | Scientific Reports | 2020 | 256 | 238 | |||
| Projection-space implementation of deep learning-guided low-dose brain PET imaging improves performance over implementation in image-space | Journal of Nuclear Medicine | 2020 | 362 | 1 | |||
| Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohort | BMC Neurology | 2020 | 324 | 142 | |||
| Microbleeds and Medial Temporal Atrophy Determine Cognitive Trajectories in Normal Aging: A Longitudinal PET-MRI Study | Journal of Alzheimer's Disease | 2020 | 280 | 535 | |||
| Higher availability of α4β2 nicotinic receptors (nAChRs) in dorsal ACC is linked to more efficient interference control | NeuroImage | 2020 | 618 | 308 | |||
| Deep learning‐guided joint attenuation and scatter correction in multitracer neuroimaging studies | Human Brain Mapping | 2020 | 382 | 162 | |||
| Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies | Movement Disorders | 2020 | 388 | 158 | |||
| [68Ga]Ga-PSMA-11 in prostate cancer: a comprehensive review | American journal of nuclear medicine and molecular imaging | 2020 | 203 | 162 | |||
| Basal forebrain metabolism in Alzheimer's disease continuum: relationship with education | Neurobiology of Aging | 2020 | 446 | 0 | |||
| Feeling of presence in dementia with Lewy bodies is related to reduced left frontoparietal metabolism | Brain Imaging and Behavior | 2020 | 423 | 145 | |||
| Extrastriatal 123I-FP-CIT SPECT impairment in degenerative parkinsonisms | Parkinsonism & Related Disorders | 2020 | 452 | 1 | |||
| Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease | European Journal of Nuclear Medicine and Molecular Imaging | 2020 | 413 | 6 | |||
| Assessment of Lesion Detectability in Dynamic Whole-Body PET Imaging Using Compartmental and Patlak Parametric Mapping | Clinical Nuclear Medicine | 2020 | 331 | 5 | |||
| Less agreeable, better preserved? A PET amyloid and MRI study in a community-based cohort | Neurobiology of Aging | 2020 | 320 | 1 | |||
| A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer's Disease in Subjects with Mild Cognitive Impairment | Current Alzheimer research | 2020 | 107 | 249 | |||
| Learning from the Past: a Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's Disease | Current Alzheimer Research | 2020 | 359 | 7 | |||
| EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 | European Journal of Nuclear Medicine and Molecular Imaging | 2020 | 317 | 350 | |||
| 3D printing for dosimetric optimization and quality assurance in small animal irradiations using megavoltage X-rays | Zeitschrift für Medizinische Physik | 2020 | 1,028 | 3 | |||
| COVID-19 and the brain: impact on nuclear medicine in neurology | European Journal of Nuclear Medicine and Molecular Imaging | 2020 | 262 | 0 | |||
| Proven validity and management impact of amyloid imaging in Alzheimer's disease-repetita juvant | European Journal of Nuclear Medicine and Molecular Imaging | 2020 | 182 | 0 | |||
| Preserved Extrastriatal 123I-FP-CIT Binding in Scans Without Evidence of Dopaminergic Deficit (SWEDD) | Molecular Imaging and Biology | 2020 | 356 | 0 | |||
| Metabolic patterns across core features in dementia with lewy bodies | Annals of Neurology | 2019 | 414 | 2 | |||
| Gray Matter Densities in Limbic Areas and APOE4 Independently Predict Cognitive Decline in Normal Brain Aging | Frontiers in Aging Neuroscience | 2019 | 311 | 177 | |||
| Amyloid Load, Hippocampal Volume Loss, and Diffusion Tensor Imaging Changes in Early Phases of Brain Aging | Frontiers in Neuroscience | 2019 | 328 | 359 | |||
| The predictive value of hypometabolism in focal epilepsy: a prospective study in surgical candidates | European Journal of Nuclear Medicine and Molecular Imaging | 2019 | 329 | 0 | |||
| The A/T/N model applied through imaging biomarkers in a memory clinic | European Journal of Nuclear Medicine and Molecular Imaging | 2019 | 425 | 6 | |||
| Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study | European Journal of Nuclear Medicine and Molecular Imaging | 2019 | 298 | 0 | |||
| Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC) | NeuroImage: Clinical | 2019 | 354 | 176 | |||
| Nicotinic receptor abnormalities as a biomarker in idiopathic generalized epilepsy | European Journal of Nuclear Medicine and Molecular Imaging | 2019 | 652 | 530 | |||
| Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal 123I-FP-CIT indices | Journal of Neurology | 2019 | 416 | 228 | |||
| Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI | Medical Oncology | 2019 | 353 | 0 | |||
| Morphological and Advanced Imaging of Epilepsy: Beyond the Basics | Children | 2019 | 370 | 263 | |||
| Higher nicotinic receptor availability in the cingulo-insular network is associated with lower cardiac parasympathetic tone | Journal of Comparative Neurology | 2019 | 440 | 0 | |||
| Does whole-body Patlak 18F-FDG PET imaging improve lesion detectability in clinical oncology? | European Radiology | 2019 | 632 | 711 | |||
| Hippocampal Volume Loss, Brain Amyloid Accumulation, and APOE Status in Cognitively Intact Elderly Subjects | Neurodegenerative Diseases | 2019 | 313 | 0 | |||
| The role of molecular imaging in assessing degenerative parkinsonism – an updated review | Swiss Medical Weekly | 2018 | 782 | 346 | |||
| Hybrid PET-MRI in Alzheimer's Disease Research | Methods in Molecular Biology | 2018 | 591 | 1 | |||
| Education-Adjusted Normality Thresholds for FDG-PET in the Diagnosis of Alzheimer Disease | Neurodegenerative Diseases | 2018 | 474 | 0 | |||
| Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study | Journal of the Neurological Sciences | 2018 | 569 | 0 | |||
| Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia | European Journal of Nuclear Medicine and Molecular Imaging | 2018 | 505 | 243 | |||
| Accuracy of whole-body HDP SPECT/CT, FDG PET/CT, and their combination for detecting bone metastases in breast cancer: an intra-personal comparison | American Journal of Nuclear Medicine and Molecular Imaging | 2018 | 476 | 160 | |||
| First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9 | EJNMMI Research | 2018 | 387 | 204 | |||
| Combined 123I-FP-CIT SPECT semiquantitative and visual assessment in parkinsonian syndromes and dementia with Lewy bodies - response to Kawada et al | Journal of the Neurological Sciences | 2018 | 444 | 1 | |||
| Dopaminergic imaging separates normal pressure hydrocephalus from its mimics | Journal of Neurology | 2018 | 452 | 0 | |||
| Incidental 18F-FDG Uptake of the Pubic Ramus and Abdominal Muscles due to Athletic Pubalgia During Acute Prostatitis | Molecular Imaging and Radionuclide Therapy | 2018 | 373 | 240 | |||
| 123I-FP-CIT SPECT Accurately Distinguishes Parkinsonian From Cerebellar Variant of Multiple System Atrophy | Clinical Nuclear Medicine | 2018 | 609 | 6 | |||
| Consolidation of a Learned Skill Correlates with Dopamine SPECT Uptake in Early Parkinson's Disease | Journal of Clinical Neurology | 2018 | 498 | 259 | |||
| The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An 18F-MISO PET-MRI Study | International Journal of Radiation Oncology, Biology, Physics | 2018 | 491 | 0 | |||
| AMYPAD Diagnostic and Patient Management Study: Rationale and design | Alzheimer's & Dementia | 2018 | 477 | 329 | |||
| Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis | European journal of nuclear medicine and molecular imaging | 2017 | 494 | 0 | |||
| Gender differences in healthy aging and Alzheimer's Dementia: A18F-FDG-PET study of brain and cognitive reserve | Human Brain Mapping | 2017 | 413 | 0 | |||
| The added value of combined visual and semi-quantitative assessment for (123)I-FP-CIT SPECT and reply to Ueda et al | Neurological Sciences | 2017 | 445 | 0 | |||
| FDG PET/MR imaging in major neurocognitive disorders | Current Alzheimer research | 2017 | 762 | 6 | |||
| Source-Based Morphometry Multivariate Approach to Analyze [(123)I]FP-CIT SPECT Imaging | Molecular imaging and biology | 2017 | 457 | 0 | |||
| Long-term Results of a Comparative PET/CT and PET/MRI Study of 11 C-Acetate and 18 F-Fluorocholine for Restaging of Early Recurrent Prostate Cancer | Clinical nuclear medicine | 2017 | 602 | 2 | |||
| Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of aging | 2017 | 478 | 1 | |||
| Guide à la lecture et interprétation de l'imagerie PET des plaques amyloïdes | Médecine nucléaire | 2017 | 520 | 6 | |||
| Whole-Body SPECT/CT versus Planar Bone Scan with Targeted SPECT/CT for Metastatic Workup | BioMed Research International | 2017 | 683 | 376 | |||
| Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of aging | 2017 | 516 | 0 | |||
| Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers | The Lancet Neurology | 2017 | 691 | 7 | |||
| Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease | NeuroImage: Clinical | 2017 | 586 | 235 | |||
| The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET : the autoimmune encephalitis | European journal of nuclear medicine and molecular imaging | 2017 | 65 | 23 | |||
| Added Value of Combined Semi-Quantitative and Visual [123I]FP-CIT SPECT Analyses for the Diagnosis of Dementia With Lewy Bodies | Clinical nuclear medicine | 2017 | 613 | 1 | |||
| CO2BOLD assessment of moyamoya syndrome: Validation with single photon emission computed tomography and positron emission tomography imaging | World journal of radiology | 2016 | 518 | 0 | |||
| Discriminating among degenerative parkinsonisms using advanced 123I-ioflupane SPECT analyses | NeuroImage. Clinical | 2016 | 682 | 239 | |||
| Severe early basal ganglia hypometabolism in neurodegeneration with brain iron accumulation | European journal of nuclear medicine and molecular imaging | 2016 | 446 | 1 | |||
| Parkinsonism Differentiates Idiopathic Normal Pressure Hydrocephalus from Its Mimics | Journal of Alzheimer's disease | 2016 | 555 | 1 | |||
| No more SWEDDs | Movement disorders | 2016 | 521 | 0 | |||
| Imagerie cérébrale de la maladie d'Alzheimer : état de l'art et perspectives pour le clinicien | Revue médicale suisse | 2016 | 662 | 11 | |||
| Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging | European radiology | 2016 | 725 | 74 | |||
| Erratum to: Dual-phase amyloid PET: hitting two birds with one stone | European journal of nuclear medicine and molecular imaging | 2016 | 450 | 0 | |||
| Yield of MRI, high-density electric source imaging (HD-ESI), SPECT and PET in epilepsy surgery candidates | Clinical neurophysiology | 2016 | 730 | 1 | |||
| Scan without evidence of dopaminergic deficit: A 10-year retrospective study | Parkinsonism & related disorders | 2016 | 531 | 0 | |||
| Establishing On-Site Reference Values for 123I-FP-CIT SPECT (DaTSCAN®) Using a Cohort of Individuals with Non-Degenerative Conditions | Molecular imaging and biology | 2016 | 652 | 5 | |||
| Re: Cranial irradiation significantly reduces beta amyloid plaques in the brain and improves cognition in a murine model of Alzheimer's Disease (AD) | Radiotherapy and oncology | 2016 | 550 | 1 | |||
| Distinct spatiotemporal patterns for disease duration and stage in Parkinson's disease | European journal of nuclear medicine and molecular imaging | 2016 | 730 | 1 | |||
| Target Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular Imaging | Frontiers in oncology | 2016 | 597 | 213 | |||
| Impulse control disorder in PD: A lateralized monoaminergic frontostriatal disconnection syndrome? | Parkinsonism & related disorders | 2016 | 507 | 0 | |||
| All-in-one interictal presurgical imaging in patients with epilepsy: single-session EEG/PET/(f)MRI | European journal of nuclear medicine and molecular imaging | 2015 | 786 | 6 | |||
| Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients | Nuclear-Medizin | 2015 | 619 | 0 | |||
| Hybrid PET/MRI as a tool to detect brown adipose tissue: Proof of principle | Obesity research & clinical practice | 2015 | 594 | 0 | |||
| Neuroimaging of the vulnerable plaque | Current vascular pharmacology | 2015 | 704 | 0 | |||
| PET Molecular Imaging of Hypoxia in Ischemic Stroke: An Update | Current vascular pharmacology | 2015 | 508 | 0 | |||
| A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives | European journal of nuclear medicine and molecular imaging | 2015 | 461 | 0 | |||
| Qualitative and Quantitative Evaluation of Blob-Based Time-of-Flight PET Image Reconstruction in Hybrid Brain PET/MR Imaging | Molecular imaging and biology | 2015 | 545 | 0 | |||
| Teaching NeuroImages: Drug-induced parkinsonism with asymmetrical putaminal DaT binding | Neurology | 2015 | 504 | 0 | |||
| Editorial: is ischemic stroke an inflammatory disease? | Current vascular pharmacology | 2015 | 433 | 0 | |||
| Dopaminergic denervation is not necessary to induce gait disorders in atypical parkinsonian syndrome | Journal of the neurological sciences | 2015 | 703 | 2 | |||
| Subcortical and Deep Cortical Atrophy in Frontotemporal Dementia due to Granulin Mutations | Dementia and geriatric cognitive disorders. Extra | 2014 | 435 | 0 | |||
| First imaging results of an intraindividual comparison of 11C-acetate and 18F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy | European journal of nuclear medicine and molecular imaging | 2014 | 790 | 1 | |||
| Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting | NeuroImage. Clinical | 2014 | 483 | 0 | |||
| Localization of the epileptogenic tuber with electric source imaging in patients with tuberous sclerosis | Epilepsy research | 2014 | 717 | 0 | |||
| Association of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain | Neuropsychopharmacology | 2014 | 445 | 2 | |||
| Cholinergic activity correlates with reserve proxies in Alzheimer's disease | Neurobiology of aging | 2013 | 460 | 0 | |||
| TEP/IRM hybride en neuro-imagerie | Médecine nucléaire | 2013 | 969 | 4 | |||
| Approaches for the optimization of MR protocols in clinical hybrid PET/MRI studies | Magma | 2013 | 741 | 420 | |||
| Neuroimaging of dementia in 2013: what radiologists need to know | European radiology | 2013 | 645 | 513 | |||
| In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease | Parkinsonism & related disorders | 2013 | 465 | 0 | |||
| Pseudoprogression after proton beam irradiation for a choroid plexus carcinoma in pediatric patient: MRI and PET imaging patterns | Child's nervous system | 2013 | 663 | 320 | |||
| Spinal uptake mimicking metastasis in SPECT/CT bone scan in a patient with superior vena cava obstruction | Clinical nuclear medicine | 2013 | 530 | 0 | |||
| Tracking the source of cerebellar epilepsy: hemifacial seizures associated with cerebellar cortical dysplasia | Epilepsy research | 2013 | 667 | 1 | |||
| Radiologic patterns of necrosis after proton therapy of skull base tumors | Canadian journal of neurological sciences | 2013 | 554 | 371 | |||
| Regions of interest-based discriminant analysis of DaTSCAN SPECT and FDG-PET for the classification of dementia | Clinical nuclear medicine | 2013 | 780 | 3 | |||
| Molecular imaging of dementia: recent developments and future perspectives | 2013 | 679 | 12 | ||||
| Peripheral nerves, tumors, and hybrid PET-MRI | Clinical nuclear medicine | 2013 | 551 | 1 | |||
| Clinical applications of hybrid PET/MRI in neuroimaging | Clinical nuclear medicine | 2013 | 791 | 2 | |||
| Beyond cognitive reserve: behavioural reserve hypothesis in Frontotemporal Dementia | Behavioural brain research | 2013 | 490 | 0 | |||
| A European multicentre PET study of fibrillar amyloid in Alzheimer's disease | European journal of nuclear medicine and molecular imaging | 2013 | 437 | 423 | |||
| Quadrimodal localization of epileptic focus using simultaneous EEG, MRI, and PET imaging | International Conference on Basic and Clinical Multimodal Imaging (BaCI) | 2013 | 36 | 0 | |||
| PET radiotracers for molecular imaging in dementia | Current radiopharmaceuticals | 2013 | 600 | 0 | |||
| Education and occupation provide reserve in both ApoE ε4 carrier and noncarrier patients with probable Alzheimer's disease | Neurological sciences | 2012 | 42 | 0 | |||
| Applications cliniques de l'imagerie hybride TEP-IRM | Médecine nucléaire | 2012 | 840 | 6 | |||
| Nature versus nurture in frontotemporal lobar degeneration : the interaction of genetic background and education on brain damage | Dementia and geriatric cognitive disorders | 2012 | 51 | 0 | |||
| 18F-FDG PET/CT and contrast-enhanced CT in a one-stop diagnostic procedure: a better strategy for management of patients suffering from retroperitoneal fibrosis? | Clinical nuclear medicine | 2012 | 600 | 0 | |||
| Individual detection of patients with Parkinson disease using support vector machine analysis of diffusion tensor imaging data: initial results | American journal of neuroradiology | 2012 | 656 | 0 | |||
| A PET-MRI case of corticocerebellar diaschisis after stroke | Clinical nuclear medicine | 2011 | 46 | 0 | |||
| ⁹⁰Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT) | European journal of nuclear medicine and molecular imaging | 2011 | 682 | 281 | |||
| In vivo evidence for GABAA receptor changes in the sensorimotor system in primary dystonia | Movement disorders | 2011 | 46 | 0 | |||
| The logopenic/phonological variant of primary progressive aphasia | Neurology | 2008 | 112 | 305 |
